Evidence map›Paper›PMID 32638094›Full record

ReviewDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft2021

[Results of the Dry Eye Research Grant Award 2016].

A Musayeva, A Gericke, F Jäger, F Paulsen, M Braun, B Fabry, R Braun, D Pauly, C Holtmann, G Geerling and 1 more

Open access · hybridAbstract readReview
In one paragraph

Review in Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

A MusayevaAugenklinik und Poliklinik, Klinikum der Johannes-Gutenberg-Universität Mainz, Mainz, Deutschland.
A GerickeAugenklinik und Poliklinik, Klinikum der Johannes-Gutenberg-Universität Mainz, Mainz, Deutschland.
F JägerInstitut für Funktionelle und Klinische Anatomie, FAU Erlangen-Nürnberg, Erlangen, Deutschland.
F PaulsenInstitut für Funktionelle und Klinische Anatomie, FAU Erlangen-Nürnberg, Erlangen, Deutschland.
M BraunInstitut für Physik der kondensierten Materie, FAU Erlangen-Nürnberg, Erlangen, Deutschland.
B FabryInstitut für Physik der kondensierten Materie, FAU Erlangen-Nürnberg, Erlangen, Deutschland.
R BraunKlinik und Poliklinik für Augenheilkunde, Universitätsklinikum Regensburg, Regensburg, Deutschland.
D PaulyKlinik und Poliklinik für Augenheilkunde, Universitätsklinikum Regensburg, Regensburg, Deutschland.
C HoltmannKlinik für Augenheilkunde, Universitätsklinikum Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
G GeerlingKlinik für Augenheilkunde, Universitätsklinikum Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland. karin.spuling@med.uni-duesseldorf.de.ORCID http://orcid.org/0000-0003-2034-3687
Sicca-Preis-Jury
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEDüsseldorf University Hospital · DEJohannes Gutenberg University Mainz · DEKlinik und Poliklinik für Augenheilkunde Universitätsklinikum Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Sicca-Förderpreis (Dry Eye Award) supports the development of scientific research on the pathogenesis, diagnostics, and treatment of dry eye and ocular surface diseases. It is awarded after a limited call for proposals in German-speaking countries, written application and selection of the award winner after evaluation by a jury of ophthalmologists working in basic and clinical science. In this article examples of the results of funded projects of the Sicca-Förderpreis 2016 are cursorily described, which were presented at the Ophthalmological Academy of Germany 2019 (Augenärztliche Akademie Deutschland 2019) and therefore provide an insight into current scientific developments. The role of muscarinic receptors and those of urea in the pathogenesis of dry eye as well as the (missing) correlation of tear film stability, viscosity and surface tension are highlighted. A project on the early detection of ocular involvement in graft versus host disease and the idea of treating meibomian gland dysfunction with eyelid surgery techniques are also groundbreaking. The outlined projects represent the potential for further substantial developments in the understanding, diagnostics and treatment of dry eye; however, their long-term clinical relevance still needs to be established.

Indexed as

Awards and PrizesDry Eye SyndromesEyelid DiseasesGermanyHumansMeibomian GlandsTearsEyelid tensionGraft versus host diseaseMuscarinic receptorTear film stabilityUrea

Identifiers

PMID32638094
PMCPMC8043874
OpenAlexW3041505886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.